News – M E G C T

25th Razi Medical Sciences and Research Festival

razi medical sciences research festival — The 25th Razi Medical Sciences and Research Festival was held on 27 day 98 by the Deputy of technology and research, Ministry of health, medical education, Tehran, Iran. This event is the most prestigious festival in health and medical sciences. Several published articles, books, patents, Journals and startups were participated in this competition. The MEGCT Co. was awarded a third prize for its effort in the field of CAR-T Cell therapy

Virtual Exhibition (3D)

Click on the links below to see the brochure and poster.

Brochure Poster teaser

CAR T Cell Meeting Melia Sitges, Sitges, Spain

the 2nd edition of the European Hematology Association — The 2nd edition of the European Hematology Association (EHA) and European Society for Blood and Marrow Transplantation (EBMT) 2020 conference will take place 30 January to 1 February 2020 at the Melia Sitges Hotel, Barcelona, Spain. European CAR T Cell Meeting focuses on Informed design of engineered T cell therapies for cancer, Acute leukemia, Myeloma, Lymphoma, Targeted genomic insertion, Engineering Next-Generation CAR T cells to Overcome Resistance, Post-transplant relapse-Second SCT or CAR T-cells and etc.

Technology Transfer of CAR T Cell Therapy

Shanghai SunBio Bio_Medicine Technology Co., Ltd, its affiliates and subsidiaries is a developer and manufacturer of Gene & Cell Therapy and Stem Cell Therapy. ME Gene Therapy and its affiliates (MEGCT) is a corporation and specialized in Gene Therapy related technology development and commercialization. SunBio and MEGCT intend to develop all advanced Gene & Cell Therapy and Stem Cell Therapy Technologies and Services. On the basis of the meeting held in China on Nov,23,2019, SunBio and MEGCTP agree to conduct in-depth cooperation in Gene & Cell Therapy and Stem Therapy.

3rd National Stem Cell Award

3rd National Stem Cell Award — According to the International Department of Stem Cell and Regenerative Medicine Council, Dr. Sahar Shojaei has been awarded the 3rd National Stem Cell and Regenerative Medicine Award for her extraordinary invention in the field of gene therapy " Novel gene editing system" This invention applies to genetic engineering, pharmaceutical biotechnology, and gene therapy. The high costs of producing the virus, the distance from the cell factory to the hospital, and the diminished cell viability due to gene therapy failure. Our core customers are Individual consumers, Startups, Small and Middle Sized Enterprises, Corporations, Government Agencies, Investors, Educational Institutions, Academics, Non-Profit Organizations etc.

Gene Delivery/Editing

Professional Team